Acute Kidney Injury After Efavirenz/Tenofovir Disoproxil Fumarate/Emtricitabine (Atripla) Overdose.

Ther Drug Monit

*Department of Clinical Pharmacy, Maastricht University Medical Center, Maastricht, the Netherlands; †Caphri School for Public Health and Primary Care, Maastricht, the Netherlands; ‡Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands; and Departments of §Medical Microbiology, and ¶Integrated Care, Maastricht University Medical Center, Maastricht, the Netherlands.

Published: April 2017

We describe a patient with acute renal failure and irreversible kidney damage after an overdose with the fixed dose combination of efavirenz/tenofovir disoproxil fumarate/emtricitabine (Atripla). The acute kidney injury was most probably caused by tenofovir. Efavirenz and emtricitabine seemed relatively safe in overdose. The pharmacokinetics in overdose of all 3 drugs and the effect of hemodialysis on the tenofovir clearance were studied by measuring the plasma concentrations and by the use of clinical pharmacokinetic software.

Download full-text PDF

Source
http://dx.doi.org/10.1097/FTD.0000000000000386DOI Listing

Publication Analysis

Top Keywords

acute kidney
8
kidney injury
8
efavirenz/tenofovir disoproxil
8
disoproxil fumarate/emtricitabine
8
fumarate/emtricitabine atripla
8
injury efavirenz/tenofovir
4
overdose
4
atripla overdose
4
overdose describe
4
describe patient
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!